BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1270 related articles for article (PubMed ID: 17136093)

  • 1. Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints.
    Bartkova J; Rezaei N; Liontos M; Karakaidos P; Kletsas D; Issaeva N; Vassiliou LV; Kolettas E; Niforou K; Zoumpourlis VC; Takaoka M; Nakagawa H; Tort F; Fugger K; Johansson F; Sehested M; Andersen CL; Dyrskjot L; Ørntoft T; Lukas J; Kittas C; Helleday T; Halazonetis TD; Bartek J; Gorgoulis VG
    Nature; 2006 Nov; 444(7119):633-7. PubMed ID: 17136093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication.
    Di Micco R; Fumagalli M; Cicalese A; Piccinin S; Gasparini P; Luise C; Schurra C; Garre' M; Nuciforo PG; Bensimon A; Maestro R; Pelicci PG; d'Adda di Fagagna F
    Nature; 2006 Nov; 444(7119):638-42. PubMed ID: 17136094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose-dependent oncogene-induced senescence in vivo and its evasion during mammary tumorigenesis.
    Sarkisian CJ; Keister BA; Stairs DB; Boxer RB; Moody SE; Chodosh LA
    Nat Cell Biol; 2007 May; 9(5):493-505. PubMed ID: 17450133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncogene-induced senescence as an initial barrier in lymphoma development.
    Braig M; Lee S; Loddenkemper C; Rudolph C; Peters AH; Schlegelberger B; Stein H; Dörken B; Jenuwein T; Schmitt CA
    Nature; 2005 Aug; 436(7051):660-5. PubMed ID: 16079837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncogene-induced senescence: putting the brakes on tumor development.
    Braig M; Schmitt CA
    Cancer Res; 2006 Mar; 66(6):2881-4. PubMed ID: 16540631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tipping the balance: Cdk2 enables Myc to suppress senescence.
    Hydbring P; Larsson LG
    Cancer Res; 2010 Sep; 70(17):6687-91. PubMed ID: 20713526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA damage signalling guards against activated oncogenes and tumour progression.
    Bartek J; Bartkova J; Lukas J
    Oncogene; 2007 Dec; 26(56):7773-9. PubMed ID: 18066090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breaking news: high-speed race ends in arrest--how oncogenes induce senescence.
    Di Micco R; Fumagalli M; d'Adda di Fagagna F
    Trends Cell Biol; 2007 Nov; 17(11):529-36. PubMed ID: 17980599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumour biology: senescence in premalignant tumours.
    Collado M; Gil J; Efeyan A; Guerra C; Schuhmacher AJ; Barradas M; Benguría A; Zaballos A; Flores JM; Barbacid M; Beach D; Serrano M
    Nature; 2005 Aug; 436(7051):642. PubMed ID: 16079833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterogeneity in premature senescence by oxidative stress correlates with differential DNA damage during the cell cycle.
    Chen JH; Ozanne SE; Hales CN
    DNA Repair (Amst); 2005 Sep; 4(10):1140-8. PubMed ID: 16006199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncogene- and tumor suppressor gene-mediated suppression of cellular senescence.
    Larsson LG
    Semin Cancer Biol; 2011 Dec; 21(6):367-76. PubMed ID: 22037160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SV40 oncoproteins enhance asbestos-induced DNA double-strand breaks and abrogate senescence in murine mesothelial cells.
    Pietruska JR; Kane AB
    Cancer Res; 2007 Apr; 67(8):3637-45. PubMed ID: 17440075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncogene-induced replication stress preferentially targets common fragile sites in preneoplastic lesions. A genome-wide study.
    Tsantoulis PK; Kotsinas A; Sfikakis PP; Evangelou K; Sideridou M; Levy B; Mo L; Kittas C; Wu XR; Papavassiliou AG; Gorgoulis VG
    Oncogene; 2008 May; 27(23):3256-64. PubMed ID: 18084328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Senescence and serration: a new twist to an old tale.
    Minoo P; Jass JR
    J Pathol; 2006 Oct; 210(2):137-40. PubMed ID: 16917802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncogene-induced cellular senescence.
    Chandeck C; Mooi WJ
    Adv Anat Pathol; 2010 Jan; 17(1):42-8. PubMed ID: 20032638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The leukemia-associated cytoplasmic nucleophosmin mutant is an oncogene with paradoxical functions: Arf inactivation and induction of cellular senescence.
    Cheng K; Grisendi S; Clohessy JG; Majid S; Bernardi R; Sportoletti P; Pandolfi PP
    Oncogene; 2007 Nov; 26(53):7391-400. PubMed ID: 17546053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CDC6: from DNA replication to cell cycle checkpoints and oncogenesis.
    Borlado LR; Méndez J
    Carcinogenesis; 2008 Feb; 29(2):237-43. PubMed ID: 18048387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Many roads lead to oncogene-induced senescence.
    Courtois-Cox S; Jones SL; Cichowski K
    Oncogene; 2008 May; 27(20):2801-9. PubMed ID: 18193093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased replication initiation and conflicts with transcription underlie Cyclin E-induced replication stress.
    Jones RM; Mortusewicz O; Afzal I; Lorvellec M; García P; Helleday T; Petermann E
    Oncogene; 2013 Aug; 32(32):3744-53. PubMed ID: 22945645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular signaling and genetic pathways of senescence: Its role in tumorigenesis and aging.
    Zhang H
    J Cell Physiol; 2007 Mar; 210(3):567-74. PubMed ID: 17133363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 64.